TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -3 | -13 | -26 | -19 | 36 | -4 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/14 19:22 | 9/17/14 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Waugh Jacob | CA | O | Chief Sc | M.d | 538 | 7.76 | 3 | 69 | 25 | D | -41 | -32 | -4 | -7 | -3 | 6 | 0 | 0 | -13 | -15 | -3 | 47 | |||
9/19/14 19:22 | 9/17/14 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Waugh Jacob | CA | O | Chief Sc | S.d | -2,025 | 20.73 | 3 | -98 | -80 | 25 | D | -41 | -32 | -4 | -7 | -3 | 6 | 0 | 0 | -13 | -15 | -3 | 47 | ||
8/20/14 16:54 | 8/18/14 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Waugh Jacob | CA | O | Chief Sc | S | -612 | 24.47 | 7 | -25 | -32 | 53 | D | -7 | -22 | -22 | -24 | -4 | -2 | -4 | -5 | -12 | -36 | -35 | 25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |